Cargando…
Approaches and genetic determinants in predicting response to neoadjuvant chemotherapy in locally advanced gastric cancer
Gastric cancer remains a major health burden worldwide. There is near-universal agreement that neoadjuvant chemotherapy (NAC) is a preferred management for locally advanced gastric cancer (LAGC). However, the optimal approach for an individual patient is still not clear and remains controversial, wh...
Autores principales: | Zhou, Jichun, Shen, Jianguo, Seifer, Benjamin J., Jiang, Shaojie, Wang, Ji, Xiong, Hanchu, Xie, Lingmin, Wang, Linbo, Sui, Xinbing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444758/ https://www.ncbi.nlm.nih.gov/pubmed/27802185 http://dx.doi.org/10.18632/oncotarget.12955 |
Ejemplares similares
-
Oncogenic mechanisms of Lin28 in breast cancer: new functions and therapeutic opportunities
por: Xiong, Hanchu, et al.
Publicado: (2017) -
Effects of core needle biopsy and subsequent neoadjuvant chemotherapy on molecular alterations and outcome in breast cancer
por: Xie, Lingmin, et al.
Publicado: (2018) -
FOLFOX versus EOX as a neoadjuvant chemotherapy regimen for patients with advanced gastric cancer
por: CHEN, WENJUN, et al.
Publicado: (2014) -
Overexpression of Lin28 Decreases the Chemosensitivity of Gastric Cancer Cells to Oxaliplatin, Paclitaxel, Doxorubicin, and Fluorouracil in Part via microRNA-107
por: Teng, Rongyue, et al.
Publicado: (2015) -
Neoadjuvant Chemotherapy in Asian Patients With Locally Advanced Gastric Cancer
por: Tong, Xie, et al.
Publicado: (2023)